Related Experiment Video
Updated: Jul 9, 2026
15:27
Construction of Vapor Chambers Used to Expose Mice to Alcohol During the Equivalent of all Three Trimesters of Human Development
Published on: July 13, 2014
Alcohol-driven AMPA receptor dysregulation across the lifespan.
1Loyola University Chicago Health Sciences Campus, Department of Molecular Pharmacology and Neuroscience, 2160 S 1st Ave, Maywood, IL 60153, USA.
Physiology & Behavior
|July 7, 2026
Summary
Alcohol alters brain signaling by affecting alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors (AMPARs), impacting behaviors and contributing to alcohol use disorder across the lifespan.
Area of Science:
- Neuroscience
- Pharmacology
- Addiction Research
Background:
- Alcohol consumption causes lasting changes in brain glutamate signaling.
- Alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors (AMPARs) are key players in these neuroadaptations.
- These changes affect synaptic plasticity in reward pathways, influencing behavior.
Purpose of the Study:
- To investigate the role of AMPARs in alcohol-induced neuroadaptations throughout the lifespan.
- To understand how alcohol affects AMPAR function and contributes to alcohol use disorder (AUD).
- To explore potential links between alcohol use, cognitive decline, and neurodegeneration.
Main Methods:
- Analysis of glutamate homeostasis disruption by alcohol.
- Examination of AMPAR subunit composition and trafficking changes.
- Investigation of circuit-specific synaptic plasticity alterations in reward pathways.
Main Results:
- Alcohol exposure alters AMPAR function, increasing excitatory drive and strengthening alcohol-seeking behaviors.
- Adolescent alcohol exposure disrupts brain maturation and leads to long-lasting signaling changes.
- In adults, AMPAR adaptations amplify alcohol's reinforcing effects, contributing to AUD.
- Alcohol's disruption of AMPARs may intersect with age-related cognitive decline and neurodegeneration.
Conclusions:
- AMPAR-centered mechanisms are crucial in mediating the neurobiological effects of alcohol across development.
- These AMPAR adaptations contribute significantly to the development and maintenance of alcohol use disorder.
- AMPAR dysregulation by alcohol may represent a shared pathway with age-related cognitive impairment and neurodegenerative diseases.
Related Concept Videos
01:27CNS Depressants: Alcohol and Nicotine
Ethanol, a clear colorless alcohol, has been consumed by humans for millennia, but its effects on the body are far from benign. At lower doses, it induces decreased inhibitions and loquaciousness, leading to its social appeal. However, it can cause severe consequences at higher doses, such as coma and respiratory depression, due to its zero-order elimination kinetics. Chronic ethanol abuse wreaks havoc on multiple organ systems, particularly the CNS and the liver. Abrupt cessation of ethanol...
01:29Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
01:27Pharmacodynamics in Geriatric Patients: Effects of Age
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
01:26Alzheimer's Disease: Overview
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
01:23Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
01:20Desensitization and Tachyphylaxis
Tachyphylaxis is described as a rapid decrease in response to a drug after repeated or continuous administration of the same drug dose. It is a phenomenon where the body becomes less responsive to a particular substance or intervention over time, requiring higher doses or stronger interventions to achieve the same effect. It results from adaptive changes in the body's receptors, signaling pathways, or physiological processes that occur in response to prolonged exposure to a stimulus.
Several...
Several...